Cargando…

Balancing Immunosuppressive Efficacy and Prevention of Posttransplant Diabetes—A Question of Timing and Patient Selection

Detalles Bibliográficos
Autores principales:	Wissing, Karl Martin, De Meyer, Vicky, Pipeleers, Lissa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224669/ https://www.ncbi.nlm.nih.gov/pubmed/30450448 http://dx.doi.org/10.1016/j.ekir.2018.08.013

Ejemplares similares

Posttransplant Diabetes Mellitus and Immunosuppression Selection in Older and Obese Kidney Recipients
por: Axelrod, David A., et al.
Publicado: (2021)

Hyperglycemia in the Posttransplant Period: NODAT vs Posttransplant Diabetes Mellitus
por: Gupta, Suruchi, et al.
Publicado: (2018)

Association of Extrarenal Adverse Effects of Posttransplant Immunosuppression With Sex and ABCB1 Haplotypes
por: Venuto, Rocco C., et al.
Publicado: (2015)

Treating the diabetic wound through miR inhibitor cocktails: A question of timing?
por: Roudier, Emilie, et al.
Publicado: (2022)

Reducing the immunosuppressive tumor microenvironment enhances photoimmunotherapy efficacy
por: Sioud, Mouldy
Publicado: (2021)

Delirium in the ICU: time to probe the hard questions
por: Stevens, Robert D, et al.
Publicado: (2011)

New‐onset posttransplant diabetes mellitus after haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide
por: Mangan, Brendan L., et al.
Publicado: (2020)

Selective decontamination of the digestive tract: all questions answered?
por: Bonten, Marc JM, et al.
Publicado: (2003)

Diabetes, COVID-19 and Mucormycosis: Unanswered Questions!
por: Rastogi, Ashu, et al.
Publicado: (2021)

Efficacy and outcomes of systemic chemotherapy in posttransplant and immunosuppression associated Kaposi sarcoma: Twenty years experience of a tertiary cancer center
por: Khanmammadov, Nij̇at, et al.
Publicado: (2023)

Posttransplant infections
por: Thomas, Beje, et al.
Publicado: (2019)

Stress Models of Depression: A Question of Bad Timing
por: Delcourte, Sarah, et al.
Publicado: (2017)

Topical Glucocorticoid Use and the Risk of Posttransplant Diabetes
por: Bøtker, Simon, et al.
Publicado: (2023)

Replies to the commentaries on the question of ‘Is it time to abandon the biological species concept?’
por: Wu, Chung-I, et al.
Publicado: (2020)

Statins and therapy of Alzheimer's disease: questions of efficacy versus trial design
por: Wolozin, Benjamin
Publicado: (2012)

Posttransplant Lymphoproliferative Disorders
por: Ibrahim, Hazem A. H., et al.
Publicado: (2012)

Posttransplant Metabolic Syndrome
por: Siddiqui, M. Shadab, et al.
Publicado: (2012)

Posttransplant autoimmune encephalitis
por: Cohen, Devon A., et al.
Publicado: (2018)

Posttransplant Intrarenal Lymphangiectasia
por: Kord, Ali, et al.
Publicado: (2020)

Posttransplant Complications and Comorbidities
por: Danziger-Isakov, Lara, et al.
Publicado: (2018)

Posttransplant Immune Activation: Innocent Bystander or Insidious Culprit of Posttransplant Accelerated Atherosclerosis
por: Ducloux, Didier, et al.
Publicado: (2017)

Posttransplant Tacrolimus-Induced Diabetic Ketoacidosis: Review of the Literature
por: Ammari, Zaid, et al.
Publicado: (2018)

Gestational Diabetes Mellitus: To Screen or Not to Screen?: Is this really still a question?
por: Simmons, David, et al.
Publicado: (2013)

Balancing autonomy and beneficence at the time of psychiatric discharge
por: Jain, Abhishek, et al.
Publicado: (2018)

The question of the question: impactful implementation science to address the HIV epidemic
por: Geng, Elvin H., et al.
Publicado: (2022)

Simple Energy Balance or Microbiome for Childhood Obesity Prevention?
por: Baranowski, Tom, et al.
Publicado: (2021)

The Question of Global Society in Post-Corona Time: Towards a Paradigm Shift
por: Norouzi, Mostafa, et al.
Publicado: (2021)

Cancer immunotherapy by immunosuppression
por: Prehn, Richmond T, et al.
Publicado: (2010)

Transplant Coordinators' Perceived Impact of Availability of Multiple Generic Immunosuppression Therapies on Patients, Workload, and Posttransplant Maintenance Therapy
por: Parker, K., et al.
Publicado: (2013)

The question of balance.
por: Sternberg, S S
Publicado: (1994)

Balancing Weight and Glucose in Gestational Diabetes Mellitus
por: Ryan, Edmond A.
Publicado: (2013)

Diabetes Medication Changes in Older Adults With Type 2 Diabetes: Insights Into Physician Factors and Questions Ahead
por: Alexopoulos, Anastasia-Stefania, et al.
Publicado: (2023)

Amyloid PET: A Questionable Single Primary Surrogate Efficacy Measure on Alzheimer Immunotherapy Trials
por: Høilund-Carlsen, Poul F., et al.
Publicado: (2022)

To ATP or Not To ATP: This Is the Question
por: Accardi, Alessio
Publicado: (2008)

Cutaneous plasmacytoma-like posttransplant lymphoproliferative disorder after renal transplantation with response to imiquimod 5% cream and reduced immunosuppression
por: Traboulsi, Danya, et al.
Publicado: (2019)

Value of posttransplant protocol biopsies in 2 biliary autoimmune liver diseases: A step toward personalized immunosuppressive treatment
por: Vannas, Marko, et al.
Publicado: (2022)

Translational Cancer Research: Balancing Prevention and Treatment to Combat Cancer Globally
por: Wild, Christopher P., et al.
Publicado: (2014)

Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: A Phase 3, Randomized Clinical Trial
por: Vink, Peter, et al.
Publicado: (2020)

Bolus or continuous hydrocortisone – that is the question
por: Weber-Carstens, Steffen, et al.
Publicado: (2007)

More Dengue, More Questions
por: Halstead, Scott B.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_tvaeug1ebr9qo76j0h3fg6qngf